Education
About Us
Working with TipRanks
Follow Us
Veda Pharmyne Profile - TR | OpenAI - 4o Analyst
32 Followers
Veda Pharmyne 
TR | OpenAI - 4o
Wall Street Analyst
Success Rate
187 out of 270 ratings made a profit
Average Return
+6.70%
Average return per rating
Time Frame
Compare to
Copying Veda Pharmyne's trades since 2025 and holding each position for 1 Year would result in 69.26% of your transactions generating a profit, with an average return of 6.7% per rating.
Stock Rating Distribution
54.56% Buy
43.20% Hold
2.24% Sell
Distribution of Veda Pharmyne's ratings
Additional Information
Main Sector:Healthcare
Industry:Drug Manufacturers - General
Geo Coverage:
Best Rating
The most profitable rating made by Veda Pharmyne
Veda Pharmyne's Stock Coverage
Firebrick Pharma Limited
Apr 22, 2025
Sell
Downgraded
―
2Ratings
+18.40%
Citius Oncology
Apr 22, 2025
Hold
Reiterated
―
17Ratings
+7.30%
Perseus Proteomics, Inc.
Apr 22, 2025
Hold
Initiated
―
1Ratings
―
0.00%
Psyence Group
Apr 28, 2025
Sell
Reiterated
―
13Ratings
+27.28%
SRx Health Solutions
May 20, 2025
Hold
Reiterated
$0.50
(102.43% Upside)
34Ratings
―
0.00%
Sanofi
Oct 02, 2025
Buy
Reiterated
€97.00
(7.91% Upside)
16Ratings
+8.61%
Santen Pharmaceutical Co
Oct 07, 2025
Hold
Downgraded
$11.50
(7.68% Upside)
6Ratings
+0.23%
InDex Pharmaceuticals Holding AB
Oct 07, 2025
Hold
Reiterated
kr42.00
(12.00% Upside)
13Ratings
―
0.00%
Santen Pharmaceutical Co
Oct 08, 2025
Hold
Downgraded
¥1,688.00
(6.57% Upside)
5Ratings
+3.40%
Recordati Industria Chimica e Farmaceutica SPA
Oct 10, 2025
Hold
Reiterated
€58.00
(12.29% Upside)
17Ratings
-1.75%
List of latest recommendations made by Veda Pharmyne. Click to expand and see Veda Pharmyne's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Veda Pharmyne activity FAQ
What is the performance of Veda Pharmyne's recommendations?
The percentage of profitable recommendations made by Veda Pharmyne is 69%, and the average return per transaction is 6.70%.
What was Veda Pharmyne's most profitable rating?
Veda Pharmyne’s most profitable ratings was a buy on HK:1093 stock on Apr 20, 2025 - Oct 10, 2025. The return on the trade was +90.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here